| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| C4 | Complement component 4 |
| EBV | Epstein-Barr virus |
| GM | gut microbiota |
| GPR41-GPR43 | G protein-coupled receptors |
| HCT | hematopoietic cell transplantation |
| HCV | hepatitis C virus |
| HHV-8 | human herpesvirus 8 |
| HIV | human immunodeficiency virus |
| HMP | Human Microbiome Project |
| IL10 | Interleukin 10 |
| IFN | Interferon |
| irAEs | immune related adverse events |
| LBP | LPS binding protein |
| LPS | lipopolysaccharide |
| MALT | mucosal-associated lymphoid tissue |
| MD | Microbial translocation |
| MS | multiple sclerosis |
| NF-kB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGS | next generation sequencing |
| NOD-1 | Nucleotide-binding oligomerization domain-containing protein 1 |
| NSCLC | non–small cell lung cancer |
| PAMPs | pathogen associated molecular patterns |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed cell death protein 1 ligand |
| PTLD | post-transplantation lymphoproliferative disorder |
| ROS | reactive oxygen species |
| sCD14 | soluble CD14 |
| SCFAs | short-chain fatty acids |
| SPF | specific pathogen-free |
| TLRs | Toll-like receptors |
| Th1-Th17 | T helper cells |
| Treg | regulatory T cell |
| VLP | virus-like particles |